59 trends tracked about this subject — the full history, oldest to newest below.
Beam Therapeutics has initiated legal action against a former scientist and two biotech entities over the alleged theft of base editing trade secrets.
Data-efficient artificial intelligence has accelerated the discovery of thermostable mRNA-lipid nanoparticle vaccines.
Adicet Bio's experimental CAR-T therapy sparks early lupus remissions, drawing widespread industry attention.
Endpoints News has revealed the 2026 Endpoints 11, spotlighting the most exciting startups currently shaping the biotechnology landscape.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Novo Nordisk strikes a $1.3 billion deal with Nanexa to secure long-acting obesity injection technology.
9 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
AI startup Basecamp Research raises $140 million in an oversubscribed Series C funding round.
Novartis has expanded its portfolio by licensing a preclinical radioligand asset from BoomRay in a $900M transaction.
6 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Scientific coverage highlights virtual cells built from 4D AI models and digital twins accelerating drug discovery.
2 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
An artificial intelligence-designed drug makes patients' blood look biologically younger, according to a new study.
Recent coverage examines how artificial intelligence transforms biological research, raising urgent questions about safety and guardrails.
Takeda Pharmaceutical's R&D chief Andy Plump is set to retire in June 2027 following a period of significant pipeline reorganization and regulatory success.
Bristol Myers Squibb reports successful Phase 2 results for its next-generation GPRC5D-directed CAR-T therapy targeting heavily treated myeloma patients.
A clinical trial has indicated that a drug developed through artificial intelligence may have the capacity to make patients biologically younger.
Roivant Sciences stock surges as its experimental inhaled lung disease drug hits mid-stage study goals.
Inhibrx claims a first-of-its-kind win for a long-sought immunotherapy target with new clinical data.
AstraZeneca reports significant Phase III trial wins for Tozorakimab, a COPD drug showing broad benefits for current and former smokers.
A new study suggests that a drug developed through artificial intelligence may have the potential to slow the biological process of aging.
An AI-designed drug candidate for lung disease, Rentosertib, has shown potential to reverse biological aging markers in early clinical data.
Personalized mRNA cancer vaccines are gaining momentum following Phase III success in melanoma and expanded global clinical trials.
Roche has secured a global licensing pact with Simcere Zaiming for an experimental B-cell-targeting antibody.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Smart probiotics capable of sensing high blood sugar and releasing GLP-1 on demand are driving widespread health coverage.
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Artificial intelligence in biotechnology is advancing at a pace that far outstrips existing regulatory frameworks.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A scientist has employed gene-editing techniques to breed a dog designed specifically to avoid triggering his own personal pet allergies.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
AbCellera shares surged after Phase 2 trial results for ABCL635 showed an 83% reduction in menopause-related hot flashes.
An AI system has designed 16 entirely new viruses after analyzing 9 trillion nucleotides to learn the patterns of DNA.
Large genome models have created sixteen new viruses from scratch, triggering warnings about potential misuse alongside drug-resistance research.
8 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Kindred Companion Sciences has used CRISPR gene-editing to create hypoallergenic beagles by removing a major allergy-causing protein.
Recent coverage highlights a scientific development involving a special enzyme designed to remove AGEs and de-age human tissue.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Researchers are leveraging AlphaFold3's contact modelling to redesign gene-editing proteins for increased precision and safety in DNA base editing.
MIT engineers have developed a precise method to grow and redirect artificial blood vessels and microvascular networks using magnetic fields.
De-extinction startup Colossal Biosciences is reportedly pursuing a new funding round with a target valuation between $20 billion and $30 billion.
Scientists have discovered a biotechnology shortcut allowing plants to produce real bovine casein, creating a path toward cow-free dairy proteins.
An experimental Alzheimer's drug shows early promise while raising mixed questions and triggering a stock drop.
Anthropic is entering the biotech sector with Claude Science, a new research workbench designed for drug discovery and studying overlooked diseases.
A prime‑editing tool for filamentous fungi is producing novel anti‑cancer compounds, drawing biotech attention.
A new single-injection therapy has shown the ability to reverse chronic osteoarthritis in animal subjects over a four-week period.
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Anthropic has entered the drug discovery sector with the launch of a dedicated AI research workbench and the development of internal pre-clinical trials.
Researchers are developing genetically modified hookworms capable of producing and delivering therapeutic agents directly within a living host.
A human patient has received the first experimental therapy designed to reverse cellular aging in a bid to treat age-related vision loss.